Skip to main content
Sign In

University of Colorado Denver


Beryllium BioBank

To Promote Future Research on the Effects of Beryllium Exposure

The Beryllium BioBank consists of a Data Coordinating Center, housed at the University of Colorado Denver, Colorado School of Public Health and a Core Specimen Laboratory, housed at National Jewish Health in Denver, Colorado.

The Department of Energy, assisted by a group of clinicians and scientists  from National Jewish Health, Hospital of the University of Pennsylvania, East Tennessee Pulmonary Associates, University of California-San Francisco, and University of California- Los Angeles collected clinical data and specimens for the Beryllium BioBank.  The purpose of the repository is to facilitate research by collecting de-identified biological specimens and clinical information from a large number of workers exposed to beryllium.  The BioBank does not directly conduct research.

The BioBank is a resource for future researchers to: 

  • Identify exposure and genetic risk factors that cause beryllium sensitization and disease
  • Improve the detection of beryllium sensitization and CBD
  • Define new therapeutics to be tested in the treatment of CBD
  • Understand the immune and inflammatory mechanisms that cause beryllium sensitization and CBD
  • Develop new biological markers of exposure, biological effect, and disease
  • Define clinical and physiologic aspects of beryllium sensitization and CBD
This effort is funded by the U.S. Department of Energy. ​​


© The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.